Renovo Cuts 100 Jobs
Shire Dumps Renovo's Scar Drug After Phase III Failure
By Nuala Moran
Friday, March 4, 2011
LONDON Renovo plc is shutting up the shop, announcing plans to cut more than 100 of its 110 staff and halt all clinical development, after an analysis of the failed Phase III trial of its scar prevention treatment Juvista concluded the product is ineffective.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.